Ruger(US:RGR)2025-11-05 22:03Financial Performance - For Q3 2025, net sales were $126.8 million, a 3.7% increase from $122.3 million in Q3 2024, while diluted earnings per share decreased to $0.10 from $0.28[3] - The company reported a pretax loss of $2.1 million in Q3 2025, impacted by $1.9 million in acquisition and operating costs at the new Hebron, KY facility[4] - Total net sales for the nine months ended September 27, 2025, were $395.0 million, compared to $389.9 million for the same period in 2024[6] - For the nine months ended September 27, 2025, the company reported a net loss of $7,876,000 compared to a net income of $20,086,000 for the same period in 2024[21] - The diluted earnings per share for the nine months ended September 27, 2025, was $(0.48), compared to $1.15 for the same period in 2024[27] Cash Flow and Investments - Cash generated from operations for the first nine months of 2025 was $38.8 million, with cash and short-term investments totaling $80.8 million as of September 27, 2025[11] - Cash provided by operating activities increased to $38,765,000 from $35,483,000 year-over-year[21] - Total cash and cash equivalents at the end of the period increased to $16,078,000 from $7,522,000 year-over-year[21] - The company repurchased $26,100,000 of common stock during the nine months ended September 27, 2025[21] - The company’s cash used for financing activities decreased to $35,762,000 from $39,969,000 year-over-year[21] Inventory and Production - New product sales, including the RXM pistol and Marlin lever-action rifles, accounted for $40.6 million or 33.7% of firearm sales in Q3 2025[11] - Finished goods inventories decreased by 15,500 units compared to Q3 2024, while distributors' inventories increased by 4,100 units[11] - Inventory rationalization contributed $17,002,000 to the net income for the nine months ended September 27, 2025[24] Tax and Financial Ratios - The company revised its estimated annual effective income tax rate for 2025, resulting in a $3.0 million increase to its income tax benefit, which positively impacted Q3 net income by $0.19 per share[5] - The current ratio stands at 3.5 to 1, and the company has no debt[11] Capital Expenditures - Capital expenditures for the first nine months of 2025 totaled $27.6 million, with an expectation of $35 million for the full year to support new product introductions and expanded capacity[11]